Imamura K, Kasamatsu T, Tanaka S
Laboratory of Visual Neurocomputing, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan.
Neuroscience. 2007 Jun 29;147(2):508-21. doi: 10.1016/j.neuroscience.2007.04.041. Epub 2007 Jun 1.
Adult cats lack ocular dominance plasticity, showing little change in the ocular dominance distribution following monocular deprivation. Ocular dominance plasticity is also lost in kitten visual cortex that has been continuously infused with either catecholaminergic neurotoxin, beta-adrenoreceptor blocker, or inhibitor of cyclic AMP-dependent protein kinase (protein kinase A). Complementarily, in adult cats we showed earlier that pharmacological activation of protein kinase A, albeit partially, restored ocular dominance plasticity. In the present study, we first asked whether, mediated by protein kinase A activation, the same molecular mechanisms could restore ocular dominance plasticity to kitten cortex that once lost the expression of plasticity due to prior pharmacological treatments. Concurrently with monocular deprivation, two kinds of cyclic AMP-related drugs (cholera toxin A-subunit or dibutyryl cyclic AMP) were directly infused in two types of aplastic kitten cortex pretreated with either 6-hydroxydopamine or propranolol. The combined treatment resulted in clear ocular dominance shift to the non-deprived eye, indicating that cortical plasticity was fully restored to aplastic kitten cortex. Next, to directly prove the sensitivity difference in protein kinase A activation between the immature and mature cortex, we compared the thus-obtained data in kittens with the published data derived from adult cats under the comparable experimental paradigm. The extent of ocular dominance changes following monocular deprivation was compared at different drug concentrations in the two preparations: the shifted ocular dominance distribution in aplastic kitten cortex infused with dibutyryl cyclic AMP at the lowest concentration tested and the W-shaped distribution in similarly treated adult cortex at a thousandfold-higher drug concentration that induced nearly maximal changes. We conclude that, irrespective of the animal's age, activation of protein kinase A cascades is a general mechanism to maintain ocular dominance plasticity high, their sensitivity being substantially higher in the immature than mature cortex.
成年猫缺乏眼优势可塑性,在单眼剥夺后眼优势分布几乎没有变化。在持续注入儿茶酚胺能神经毒素、β-肾上腺素能受体阻滞剂或环磷酸腺苷依赖性蛋白激酶(蛋白激酶A)抑制剂的幼猫视觉皮层中,眼优势可塑性也会丧失。与之互补的是,我们之前在成年猫中发现,蛋白激酶A的药理学激活虽然只是部分恢复,但能恢复眼优势可塑性。在本研究中,我们首先探讨,由蛋白激酶A激活介导的相同分子机制是否能将眼优势可塑性恢复到因先前药物治疗而丧失可塑性表达的幼猫皮层。在单眼剥夺的同时,将两种与环磷酸腺苷相关的药物(霍乱毒素A亚基或二丁酰环磷酸腺苷)直接注入用6-羟基多巴胺或普萘洛尔预处理的两种无可塑性幼猫皮层类型中。联合治疗导致明显的眼优势向未剥夺眼转移,表明皮层可塑性完全恢复到无可塑性的幼猫皮层。接下来,为了直接证明未成熟和成熟皮层在蛋白激酶A激活方面的敏感性差异,我们在可比的实验范式下,将幼猫中获得的数据与成年猫已发表的数据进行了比较。在两种制剂中,比较了不同药物浓度下单眼剥夺后眼优势变化的程度:在测试的最低浓度下注入二丁酰环磷酸腺苷的无可塑性幼猫皮层中眼优势分布的转移,以及在诱导几乎最大变化的高一千倍药物浓度下类似处理的成年皮层中的W形分布。我们得出结论,无论动物年龄如何,蛋白激酶A级联的激活是维持高眼优势可塑性的一般机制,其在未成熟皮层中的敏感性远高于成熟皮层。